back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-08-18 12:53 Tx date 2026-08-17 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+90,000 vol |
215,833 | |
| Filed 2026-08-18 12:42 Tx date 2026-08-17 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-90,000 vol |
0 | |
| Filed 2026-08-13 09:29 Tx date 2026-08-10 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+90,000 vol |
90,000 | |
| Filed 2026-06-30 14:01 Tx date 2025-01-06 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-60,000 vol |
0 | |
| Filed 2026-06-30 13:54 Tx date 2026-04-21 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-225,000 vol |
25,000 | |
| Filed 2026-06-30 13:54 Tx date 2025-03-06 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2026-06-30 13:53 Tx date 2025-11-05 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-24,000 vol |
0 | |
| Filed 2026-06-30 13:52 Tx date 2026-06-17 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$35,000
+87,500 vol $0.40 each |
87,500 | |
| Filed 2026-06-30 13:51 Tx date 2025-11-05 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-33,332 vol |
0 | |
| Filed 2026-06-30 13:49 Tx date 2025-01-05 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-60,000 vol |
40,000 | |
| Filed 2026-06-30 13:49 Tx date 2025-01-05 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-60,000 vol |
||
| Filed 2026-06-30 13:48 Tx date 2025-01-06 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-40,000 vol |
0 | |
| Filed 2026-06-30 13:47 Tx date 2026-04-21 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-43,200 vol |
4,800 | |
| Filed 2026-06-30 13:46 Tx date 2026-06-17 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$35,000
+87,500 vol $0.40 each |
125,833 | |
| Filed 2026-06-30 13:45 Tx date 2026-04-21 |
$AGN
Grey Matters Health Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-344,999 vol |
38,333 | |
| Filed 2024-02-08 13:58 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
383,332 | |
| Filed 2024-02-08 13:57 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-250,000 vol |
0 | |
| Filed 2024-02-04 10:55 Tx date 2024-01-30 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2024-01-04 15:51 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+66,668 vol |
133,332 | |
| Filed 2024-01-04 15:50 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-66,668 vol |
0 |